Company news
Hangzhou Diagens Biotechnology Co., Ltd. news
Latest news releases, newest first.
Voluntary announcement - entering into a strategic cooperation agreement with yongjiang laboratory
November 6, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 4, 2026
Grant of options and restricted share units under the 2026 share incentive scheme
October 20, 2026
Change of company logo
October 20, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 7, 2026
Poll results of the 2026 second extraordinary general meeting held on September 30, 2026
September 30, 2026
Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
April 30, 2026